ExpansionOct 8, 2026, 08:21 AM
Aurora Cannabis Expands German Facility, Doubling Flower Output
AI Summary
Aurora Cannabis Inc. announced the completion of a significant expansion of its EU-GMP manufacturing facility in Leuna, Germany, now named Aurora Horizon. This multi-million dollar investment more than doubles the facility's expected annual flower output and enhances its capacity to produce high-quality, compliant medical cannabis for European markets. The expansion integrates Aurora's proven cultivation practices and proprietary genetics, reinforcing the company's commitment to serving patients in its fastest-growing markets and strengthening its European growth strategy.
Key Highlights
- Aurora Cannabis Inc. completed a major expansion of its EU-GMP manufacturing facility in Leuna, Germany.
- The expansion more than doubles the facility's expected annual flower output.
- The facility, renamed Aurora Horizon, now incorporates Aurora's cultivation practices and proprietary genetics.
- The expanded capacity aims to meet growing demand for high-quality medical cannabis in Germany and Europe.
- The facility has received an expanded EU-GMP license for its newly built areas.
Price Impact
More from ACB